Lazard Asset Management LLC Heron Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $227,782 - $378,982	98,182 New	98,182 $343,000
Q4 2020 Feb 11, 2021	SELL	$14.61 - $22.14 $61,069 - $92,545	-4,180 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $17,565 - $22,834	-1,285 Reduced 23.51%	4,180 $61,000
Q2 2020 Aug 13, 2020	BUY	$10.89 - $21.47 $19,188 - $37,830	1,762 Added 47.58%	5,465 $80,000
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $37,881 - $90,945	3,703 New	3,703 $43,000
Q3 2018 Nov 13, 2018	SELL	$30.0 - $40.85 $1.1 Million - $1.49 Million	-36,520 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$26.4 - $42.0 $964,128 - $1.53 Million	36,520 New	36,520 $1.42 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $138M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.